CC
CSTL icon

Centiva Capital’s Castle Biosciences CSTL Stock Holding History

Centiva Capital’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,802
Closed -$336K – 1651
2025
Q1 		$336K Sell
16,802
-6,213
-27% -$154K 0.02% 1021
2024
Q4 		$613K Buy
23,015
+3,647
+19% +$111K 0.02% 710
2024
Q3 		$552K Buy
19,368
+95
+0.5% +$2.42K 0.03% 1190
2024
Q2 		$420K Buy
19,273
+9,771
+103% +$218K 0.02% 1263
2024
Q1 		$210K Sell
9,502
-3,056
-24% -$66.5K 0.01% 1445
2023
Q4 		$271K Buy
+12,558
New +$221K 0.02% 1260

Other funds holding CSTL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $86.6B AUM 38.74% 1-Year Est. Return